- FDA approved Genentech's Gazyva as first steroid-sparing treatment for pediatric nephrotic syndrome, addressing a rare ...

A 20-year study found favorable outcomes with IVIG in several difficult skin diseases, with side effects reported in 15.4% of patients.

Minjuvi 200 mg ist ein verschreibungspflichtiges Arzneimittel mit dem Wirkstoff Tafasitamab. Das Pulver wird zu einem ...

Symptoms, Causes, and What Patients Should Know / Amivantamab, anaphylaxis, cancer, cancer treatment side effects, ...

Rituxan, also called rituximab, is a biologic medicine used for certain cancers and autoimmune disorders. It targets B cells, ...

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

The active ingredient in Truxima is rituximab-abbs. (The active ingredient is what makes a drug work.) It belongs to a group of drugs called monoclonal antibodies, and it’s a kind of immunotherapy.

Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has submitted a supplemental application to ANVISA, the Brazilian health ...

A 3:2 randomized, double-blind trial (n = 218) compared rituximab 1000 mg then 500 mg every 6 months vs ocrelizumab 600 mg every 6 months in adults 18 to 60 years with EDSS 0-4 and diagnosis ≤ 12 ...

Although rituximab may improve central nervous system outcomes, evidence supporting its use in Sjögren disease is limited. CNS involvement is an uncommon but potentially serious manifestation of ...

FDA authorized a new rituximab biosimilar based on comprehensive comparability data demonstrating high similarity to reference rituximab and no clinically meaningful clinical differences. Market ...

Immunotherapy uses the power of your immune system to fight your cancer. There are several types of immunotherapies. They include antibody therapies and CAR T-cell therapy. Immunotherapies are among ...